VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $298,115 | -31.3% | 26,930 | +3.3% | 0.00% | -50.0% |
Q1 2023 | $433,949 | +1012.7% | 26,063 | +81.2% | 0.00% | – |
Q3 2022 | $39,000 | -9.3% | 14,382 | -2.6% | 0.00% | – |
Q2 2022 | $43,000 | -20.4% | 14,763 | -17.2% | 0.00% | – |
Q1 2022 | $54,000 | -82.7% | 17,840 | -73.8% | 0.00% | -100.0% |
Q4 2021 | $313,000 | +63.9% | 68,119 | +124.0% | 0.00% | 0.0% |
Q3 2021 | $191,000 | -67.8% | 30,415 | -69.3% | 0.00% | -50.0% |
Q2 2021 | $594,000 | -11.6% | 99,166 | -6.7% | 0.00% | -50.0% |
Q1 2021 | $672,000 | +168.8% | 106,255 | +139.6% | 0.00% | +100.0% |
Q4 2020 | $250,000 | -56.9% | 44,348 | -55.5% | 0.00% | -75.0% |
Q3 2020 | $580,000 | -34.5% | 99,684 | -9.7% | 0.01% | +60.0% |
Q4 2019 | $885,000 | +59.7% | 110,347 | +37.1% | 0.01% | 0.0% |
Q3 2019 | $554,000 | -50.8% | 80,479 | -40.7% | 0.01% | -54.5% |
Q2 2019 | $1,126,000 | +123.9% | 135,718 | +168.2% | 0.01% | +120.0% |
Q1 2019 | $503,000 | -13.4% | 50,600 | -33.4% | 0.01% | -28.6% |
Q4 2018 | $581,000 | – | 75,943 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |